TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - GSK PLC Share Price

Certificat

DE000SN43HP3

Market Closed - Börse Stuttgart 08:58:18 26/04/2024 BST
5.05 EUR -1.56% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - GSK PLC
Current month-14.98%
1 month-11.87%
Date Price Change Volume
26/04/24 5.05 -1.56% 0
25/04/24 5.13 -1.72% 0
24/04/24 5.22 +1.75% 0
23/04/24 5.13 +10.32% 0
22/04/24 4.65 +7.14% 0

Delayed Quote Börse Stuttgart

Last update April 26, 2024 at 08:58 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SN43HP
ISINDE000SN43HP3
Date issued 19/07/2022
Strike 1,215 p
Maturity Unlimited
Parity 1 : 1
Emission price 3.48
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.88
Lowest since issue 1.73

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
16.53 GBP
Average target price
20.06 GBP
Spread / Average Target
+21.34%
Consensus